A turbulent decade for NSAIDs: update on current concepts of classification, epidemiology, comparative efficacy, and toxicity
about
Honaucins A-C, potent inhibitors of inflammation and bacterial quorum sensing: synthetic derivatives and structure-activity relationshipsCelecoxib for rheumatoid arthritisAspirin and anti-inflammatory drugs for the prevention of dementiaWhat we know about nonsteroidal anti-inflammatory drug hypersensitivityNew insights into the use of currently available non-steroidal anti-inflammatory drugsPharmacogenomics of Prostaglandin and Leukotriene ReceptorsSeven steps to the diagnosis of NSAIDs hypersensitivity: how to apply a new classification in real practice?A clinical and safety review of paracetamol and ibuprofen in childrenPomegranate Extracts in the Management of Men's Urologic Health: Scientific Rationale and Preclinical and Clinical Data.Long-Term (1-Year) Safety and Efficacy of a Single 6-mL Injection of Hylan G-F 20 in Indian Patients with Symptomatic Knee OsteoarthritisCelecoxib for osteoarthritis.Variants of CEP68 gene are associated with acute urticaria/angioedema induced by multiple non-steroidal anti-inflammatory drugsViscosupplementation for osteoarthritis: a primer for primary care physiciansTargeting renal purinergic signalling for the treatment of lithium-induced nephrogenic diabetes insipidus.Prevalence, trends, patterns and associations of analgesic use in GermanyValidated HPLC-UV method for determination of naproxen in human plasma with proven selectivity against ibuprofen and paracetamol.Non-steroidal anti-inflammatory drug-induced cardiovascular adverse events: a meta-analysis.An integrated safety analysis of intravenous ibuprofen (Caldolor(®)) in adults.IL-1β-induced modulation of gene expression profile in human dermal fibroblasts: the effects of Thai herbal Sahatsatara formula, piperine and gallic acid possessing antioxidant properties.Identification of non-steroidal anti-inflammatory drug use disorder: A case report.Nonsteroidal anti-inflammatory drug use, chronic liver disease, and hepatocellular carcinoma.Global epidemiology of hepatocellular carcinoma: an emphasis on demographic and regional variability.Nitric oxide-releasing sulindac is a novel skin cancer chemopreventive agent for UVB-induced photocarcinogenesis.A 12-week randomized study of topical therapy with three dosages of ketoprofen in Transfersome® gel (IDEA-033) compared with the ketoprofen-free vehicle (TDT 064), in patients with osteoarthritis of the knee.Practice guidelines for pharmacists: The pharmacological management of rheumatoid arthritis with traditional and biologic disease-modifying antirheumatic drugs.High-risk use of over-the-counter non-steroidal anti-inflammatory drugs: a population-based cross-sectional study.Influence of nonsteroidal anti-inflammatory drugs on aspirin's antiplatelet effects and suggestion of the most suitable time for administration of both agents without resulting in interaction.Management of hip involvement in ankylosing spondylitis.Non-steroidal anti-inflammatory drug use in chronic pain conditions with special emphasis on the elderly and patients with relevant comorbidities: management and mitigation of risks and adverse effects.Modulation of the pharmacokinetics, therapeutic and adverse effects of NSAIDs by Chinese herbal medicines.Omega-3 polyunsaturated fatty acids as an angelus custos to rescue patients from NSAID-induced gastroduodenal damage.Cyclooxygenase-2 Mediated Oxidation of 2-Arachidonoyl-Lysophospholipids Identifies Unknown Lipid Signaling Pathways.Nonsteroidal anti-inflammatory drugs and the risk of nonmelanoma skin cancer.Efficacy and safety of morniflumate for the treatment of symptoms associated with soft tissue inflammation.Nanofibers used for the delivery of analgesics.Nonsteroidal Anti-Inflammatory Therapy: A Journey Toward Safety.The AMPK enzyme-complex: from the regulation of cellular energy homeostasis to a possible new molecular target in the management of chronic inflammatory disorders.Management of NSAID-associated peptic ulcer disease.Synthesis and molecular docking of new imidazoquinazolinones as analgesic agents and selective COX-2 inhibitors.Non-steroidal anti-inflammatory drug related upper gastrointestinal bleeding: types of drug use and patient profiles in real clinical practice.
P2860
Q21994482-0906162F-AE28-457B-BD03-563064D645F2Q24186209-6B9EFF71-65B5-4284-8F08-1185B44B7E67Q24186992-C47686E5-D33A-48A0-B4E8-6B1AB932A446Q26749250-62F52E0E-5A59-409A-B057-CB3680720E79Q26852330-D8ADA0BB-07BA-4458-83F2-59027502B225Q28077789-A58BB073-D1FC-4042-901C-EB86D57D1AE4Q28081823-03D81237-4E99-473B-9116-40D971FB9C5EQ30239807-9DF78622-74BF-417F-9446-0371193694EAQ30617117-4AD54308-41B5-4ACC-8574-E89CF5F07F95Q34334841-8214B9D2-8B7C-4867-8FD9-865609E2130CQ34557021-D2B0C60F-98F9-4757-8113-BD34E765B879Q35117697-BA4F530D-CCD6-46DA-A3D4-E8B084DA521DQ35153951-9BF5A988-B038-408F-BE87-55F21A5D31F5Q35602671-1360DED8-7ACD-41B0-AF24-23619A65DBC8Q35795918-5D9D062D-8A96-457C-8098-D45C73121A7DQ35803449-FFF6DBC5-B84B-45D3-AD1C-F9FD53E7DF2AQ36233306-80AAC615-05C4-43ED-9D3D-6A407A42AB31Q36244274-3F4056E9-353C-48F9-A198-1B9654D91010Q36244747-5B2586EB-77F9-4946-9AB5-D9C18BD978A6Q36284813-5B34C281-F257-4A45-9CB2-DF0A73399884Q36444733-E1046146-5BFD-4938-B795-B6585A94FB55Q36461735-7D7E2FB0-0A67-4C32-B674-F07A262D185CQ37191199-E269CF51-C9C4-4C70-A10A-B20A18F3704EQ37260964-FFBE18E2-5B69-400A-A5CC-CEC1FDD7B7FAQ37654774-4785EEBE-C89D-4E0C-9FE2-36B627ACC082Q37660844-6014ADA9-C9F3-4D47-ADC8-F071E7319CB6Q37692578-A30B0372-8B3C-4431-915A-A65C3BAEAFEDQ38102540-1F9A8326-5B9D-45CC-BFCE-56E46093FD11Q38243967-37C8813B-83D4-4A6A-8399-63B501FC71C6Q38259360-F2783C8E-7C4D-42FB-B4FE-F70EC5DA5AC5Q38314106-E6D770EE-5B76-41DF-86D0-E29405B8B1C9Q38409622-EE4B55EB-911D-47E9-805C-A27A9209EC62Q38417725-C39D74CD-BD5D-41A1-AC81-594E44A44737Q38447864-DC14E67F-C2AE-4C42-A8C4-DA570703050EQ38529529-EBE3BE45-E7BF-49EC-B165-18A95E25C6D4Q38558587-2726C2E2-86DD-4894-A109-F4428130F2FAQ38594411-1980144F-2734-4FE8-8D77-C8420A9A3F88Q38699305-98469724-EDD6-4F1E-8E17-6823FE9D140FQ38732477-760426BF-D6E1-4F0F-B0C4-60EF51CB08A4Q38751407-AD71F206-C116-4087-B187-E066AEE42FA0
P2860
A turbulent decade for NSAIDs: update on current concepts of classification, epidemiology, comparative efficacy, and toxicity
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
A turbulent decade for NSAIDs: ...... arative efficacy, and toxicity
@ast
A turbulent decade for NSAIDs: ...... arative efficacy, and toxicity
@en
A turbulent decade for NSAIDs: ...... arative efficacy, and toxicity
@en-gb
A turbulent decade for NSAIDs: ...... arative efficacy, and toxicity
@nl
type
label
A turbulent decade for NSAIDs: ...... arative efficacy, and toxicity
@ast
A turbulent decade for NSAIDs: ...... arative efficacy, and toxicity
@en
A turbulent decade for NSAIDs: ...... arative efficacy, and toxicity
@en-gb
A turbulent decade for NSAIDs: ...... arative efficacy, and toxicity
@nl
prefLabel
A turbulent decade for NSAIDs: ...... arative efficacy, and toxicity
@ast
A turbulent decade for NSAIDs: ...... arative efficacy, and toxicity
@en
A turbulent decade for NSAIDs: ...... arative efficacy, and toxicity
@en-gb
A turbulent decade for NSAIDs: ...... arative efficacy, and toxicity
@nl
P2860
P921
P3181
P1476
A turbulent decade for NSAIDs: ...... arative efficacy, and toxicity
@en
P2860
P2888
P304
P3181
P356
10.1007/S00296-011-2263-6
P407
P577
2012-06-01T00:00:00Z
P5875
P6179
1026062660